Recent advance in the development of novel, selective and potent FGFR inhibitors.

导出 LinkOut

翻译打印收藏纠错

第一作者： Feng-Tao,Liu

第一单位： Laboratory of Molecular Design and Drug Discovery, School of Science, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, Jiangsu, 211198, China.

作者： Feng-Tao,Liu ^[1] ; Nian-Guang,Li ^[2] ; Yan-Min,Zhang ^[1] ; Wu-Chen,Xie ^[1] ; Si-Ping,Yang ^[1] ; Tao,Lu ^[3] ; Zhi-Hao,Shi ^[4]

作者单位： Laboratory of Molecular Design and Drug Discovery, School of Science, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, Jiangsu, 211198, China. ^[1] National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, Jiangsu, 210023, China. ^[2] Laboratory of Molecular Design and Drug Discovery, School of Science, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, Jiangsu, 211198, China. Electronic address: lutao@cpu.edu.cn. ^[3] Laboratory of Molecular Design and Drug Discovery, School of Science, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, Jiangsu, 211198, China. Electronic address: sszh163@163.com. ^[4]

关键词 Cancer FGFR Inhibitor Novel PTK Potent Selective

主题词人类(Humans);蛋白激酶抑制剂(Protein Kinase Inhibitors);受体, 成纤维细胞生长因子(Receptors, Fibroblast Growth Factor)

DOI 10.1016/j.ejmech.2019.111884

PMID 31761386

发布时间 2020-02-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

European journal of medicinal chemistry

2020年186卷

111884页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Recent advance in the development of novel, selective and potent FGFR inhibitors.

European journal of medicinal chemistry

相似文献

European journal of medicinal chemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Recent advance in the development of novel, selective and potent FGFR inhibitors.

European journal of medicinal chemistry

相似文献

European journal of medicinal chemistry

相关期刊

检索历史清除